Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-10-24

Clinical Trial Update: A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia [Phase 3]

View source ↗

Summary

This update covers a Phase 3 study evaluating eltrombopag as rescue therapy for isolated chemotherapy-induced thrombocytopenia in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eltrombopag (eltrombopag)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Solid Tumor | Phase 3 | Status: UNKNOWN